Medical science can typically provide a clear explanation of the intricacies of the human body. However, there are times when ...

A previously unknown mechanism that makes it possible for aggressive so-called triple-negative breast cancer to fine-tune its ...

Positioned to increase depth of Vafseo prescribing entering 2026 with access to approximately 275,000 patients First patient ...

Company expects preliminary unaudited AUCATZYL® net product revenue of approximately $24 million for the fourth quarter of 2025 and approximately $75 million for the full year of 2025Autolus anticipat ...

Dual anti-platelet therapy remains a cornerstone of the treatment for coronary artery disease. When choosing a second anti-platelet, ticagrelor remains a principal agent after the recent PLATO trial ...

Researchers at the Luxembourg Institute of Health have published a major review in Nature Cancer proposing a new framework to explain and potentially overcome the long-standing resistance of ...